Purpose/Objective(s): Oral vitamin E and pentoxifylline have been used to decrease fibrosis after breast-conserving surgery and radiation therapy. The hypothesis was that this regimen would improve patient-reported outcomes and implant failure rates. Materials/Methods: Women who underwent PMRT after implant-based reconstruction were eligible. Subjects were given oral vitamin E 400 IU daily and pentoxifylline 400 mg twice daily for 1 week and if tolerated were increased to 400 mg thrice daily. Vitamin E and pentoxifylline were started 1 week after completion of radiation and continued for 6 months. Breast-Q surveys were administered at enrollment prior to starting radiation and at 1-, 6-, and 18-months post-radiation therapy. Patients were monitored for implant retention at the same time intervals. Subjects were asked to keep medication diaries to evaluate toxicity and compliance. Surveys and implant failure rates were compared to a cohort of women who underwent PMRT after implantbased reconstruction in the 2 years prior to initiation of this trial. Results: Patients were enrolled from February 2018 to January 2020. A total of 27 women were enrolled; 8 were excluded from analysis. Six of the 8 women did not want to participate after completion of radiation prior to starting medications. Another patient developed cellulitis of a VP drain shunt 1 month after radiation requiring removal of breast implant and declined further participation. One patient discontinued medications after a week due to nausea and declined further participation. Of the remaining 19 patients, 2 stopped medications after 1 month due to nausea, 1 stopped after 4 months due to implant failure and another stopped after 4 months due to travel. Fifteen patients completed the 6 months of therapy. All 19 women received standard fractionation of 50 Gy in 2-Gy fractions and 3 had additional 10 Gy in 5 fractions boost to the chest wall. At time of this analysis 3 of the 19 women underwent implant removal with subsequent autologous flap reconstruction. Of these 3, one had her implants removed prior to starting radiation due to postoperative infection. There were 22 women who were enrolled in the control cohort. Of these, 3 were lost to follow-up and 19 women were available for analysis. Radiation therapy consistent of 50-50.4 Gy using standard fractionation; 11 had a chest wall boost ranging from 4-16Gy. There were 4 implant failures. In the trial group, the Breast-Q scores improved at 6 months compared to baseline (t = 3.08, P = 0.006), but there was no difference in scores between the control and trial groups. Conclusion:Oral vitamin E and pentoxifylline did not improve either implant failure rate or patient-reported outcomes compared to historical control. Limitations to this study are small patient population and differences in radiation therapy that could have impacted implant failure rate.
Background: Muscle energy technique (MET) is asn osteopathic treatment technique that is utilized frequently in the clinical setting, yet the overall effectiveness is minimally supported within literature. MET is an osteopathic technique that involves an isometric contract relax technique intended to improve alignment and enhance neuromuscular education. Objective: The purpose of this study was to determine the effectiveness of MET on running kinetics on subjects with low back pain. Method: A quasi-experimental research design was implemented and subjects, all of whom either had a history of or currently experience low back pain, underwent pre-intervention data collection of: anthropometric measurements, medical history, dorsaVi 3D running analysis, and a musculoskeletal and neurological clinical exam. Subjects underwent 6 weeks of isolated lumbo-pelvic MET at a frequency of twice a week, and were instructed to avoid all other treatment. Post-intervention data collected included a clinical exam and another dorsaVI running analysis. Results: Data was analyzed including: pre and post-treatment initial peak acceleration, ground contact time, and ground reaction force. A paired t-test comparing pre and post mean kinetic changes demonstrated the following p values: initial peak acceleration p = .80, ground contact time p = .96, and ground reaction force p = .68. Conclusion: This study demonstrated that isolated MET treatment is not statistically significant for changing 3D kinetic running variable in subjects with low back pain. Clinical Implications: Recommend healthcare providers to use a multi-treatment approach for low back pain. Future research should include a control group and larger sample size.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.